ASRA News

A Primer for Pain Physicians on Gadolinium-Based Contrast Agents: Caution Is Advised

January 13, 2021 American Society of Regional Anesthesia and Pain Medicine Season 8 Episode 11
ASRA News
A Primer for Pain Physicians on Gadolinium-Based Contrast Agents: Caution Is Advised
Chapters
ASRA News
A Primer for Pain Physicians on Gadolinium-Based Contrast Agents: Caution Is Advised
Jan 13, 2021 Season 8 Episode 11
American Society of Regional Anesthesia and Pain Medicine

"A Primer for Pain Physicians on Gadolinium-Based Contrast Agents: Caution Is Advised," by Zachary Pellis, BA, Lewis Katz School of Medicine, Philadelphia, Pennsylvania; Leonard DeRiggi, MD, Brighton Radiology Associates, Sewickley, Pennsylvania; Kim Shaftner, MD, JD, Fellow of the American College of Legal Medicine, Knott & Boyle, PLLC, Raleigh, North Carolina; David A. Provenzano, MD, Pain Diagnostics and Interventional Care, Sewickley, Pennsylvania. From ASRA News, November 2020. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.

Show Notes

"A Primer for Pain Physicians on Gadolinium-Based Contrast Agents: Caution Is Advised," by Zachary Pellis, BA, Lewis Katz School of Medicine, Philadelphia, Pennsylvania; Leonard DeRiggi, MD, Brighton Radiology Associates, Sewickley, Pennsylvania; Kim Shaftner, MD, JD, Fellow of the American College of Legal Medicine, Knott & Boyle, PLLC, Raleigh, North Carolina; David A. Provenzano, MD, Pain Diagnostics and Interventional Care, Sewickley, Pennsylvania. From ASRA News, November 2020. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.